Last reviewed · How we verify
Levobupivacaine bolus analgesia
Levobupivacaine bolus analgesia is a Small molecule drug developed by Osijek University Hospital. It is currently FDA-approved. Also known as: Postoperative wound infiltration with bolus applications of local anesthetic, Chirocaine 0.5%.
At a glance
| Generic name | Levobupivacaine bolus analgesia |
|---|---|
| Also known as | Postoperative wound infiltration with bolus applications of local anesthetic, Chirocaine 0.5% |
| Sponsor | Osijek University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Intertransverse Process Block to Improve Quality of Recovery and Pain Management in Adult Cardiac Surgical Patients (NA)
- Femoral Rami Obturator Nerve Trunk (FRONT) Block in Intramedullary Nail Surgery . (NA)
- Observational Retrospective Study on Spinal Analgesia in Laparoscopic and Laparotomic Hysterectomy
- Advantage of Tramadol in Local Analgesia Post-Sternotomy (PHASE4)
- PENG Block: Continuous Infusion vs. Programmed Intermittent Bolus in Neck of Femur Fracture (NA)
- Comparison Between Epidural Analgesia and Intrathecal Opioid Analgesia for Pain Management in Open Nephrectomy (PHASE1)
- Programmed Intermittent Epidural Bolus (PIEB) Techniques for Labour Analgesia (PHASE4)
- Does Type of Anesthesia Influence Inflammation Change After Breast Surgery? (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Levobupivacaine bolus analgesia CI brief — competitive landscape report
- Levobupivacaine bolus analgesia updates RSS · CI watch RSS
- Osijek University Hospital portfolio CI
Frequently asked questions about Levobupivacaine bolus analgesia
What is Levobupivacaine bolus analgesia?
Levobupivacaine bolus analgesia is a Small molecule drug developed by Osijek University Hospital.
Who makes Levobupivacaine bolus analgesia?
Levobupivacaine bolus analgesia is developed and marketed by Osijek University Hospital (see full Osijek University Hospital pipeline at /company/osijek-university-hospital).
Is Levobupivacaine bolus analgesia also known as anything else?
Levobupivacaine bolus analgesia is also known as Postoperative wound infiltration with bolus applications of local anesthetic, Chirocaine 0.5%.
What development phase is Levobupivacaine bolus analgesia in?
Levobupivacaine bolus analgesia is FDA-approved (marketed).
Related
- Manufacturer: Osijek University Hospital — full pipeline
- Also known as: Postoperative wound infiltration with bolus applications of local anesthetic, Chirocaine 0.5%
- Compare: Levobupivacaine bolus analgesia vs similar drugs
- Pricing: Levobupivacaine bolus analgesia cost, discount & access